Technicians Strike Back

Technicians Strike Back Thank you for your editorial of June 30.1 I am one of those research technicians you speak of, having gotten into the business 30 years ago, a refugee from a still very hostile climate in grad school (for women) with no clear job prospects at the other end and college debts. In my first years I was trained and abused by the best: the older faculty all had worked with Nobel laureates and two of the younger ones got the prize themselves. Since then, I have seen bad s

Written byKate Borland
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thank you for your editorial of June 30.1 I am one of those research technicians you speak of, having gotten into the business 30 years ago, a refugee from a still very hostile climate in grad school (for women) with no clear job prospects at the other end and college debts.

In my first years I was trained and abused by the best: the older faculty all had worked with Nobel laureates and two of the younger ones got the prize themselves.

Since then, I have seen bad science that I couldn't fix, but saved an awful lot of embarrassment for others, and currently almost single-handedly saved a program project. I've fought battles over data interpretation and ethics. I've got a new technique that will help neuroscience research greatly when it gets published. And I have trained more students, residents, and technicians than I can remember.

What I have left ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies